Peter Gassner

Peter Gassner leads Veeva Systems as CEO, having founded the company to bring cloud computing to the life sciences industry. Veeva has achieved a near-monopoly position in pharmaceutical and biotech cloud software: over 90% of the top 50 pharmaceutical companies use Veeva products. The platform spans commercial cloud (CRM for pharma sales reps, content management for regulated marketing materials), regulatory and quality (electronic submissions to FDA/EMA), and R&D (clinical trial data management, eTMF). The pharmaceutical industry has unique software requirements due to heavy regulation — every promotional material, clinical document, and regulatory submission must be managed with complete audit trails and compliance controls. Veeva's industry-specific approach creates deep switching costs: once a pharma company standardizes on Veeva, migrating away is extremely costly and risky. Gassner converted Veeva to a Public Benefit Corporation in 2021 — the largest public company to do so. Key stock drivers include subscription revenue growth and net retention rates, new product adoption within existing customers, expansion into new life sciences verticals, competition from Salesforce (former platform partner) and other enterprise software vendors, pharma industry R&D spending trends, pipeline of new Vault applications, international expansion, and the company's migration from Salesforce infrastructure to its own platform.